Over a billion people living with mental health conditions – services require urgent scale-up

Oscar Reyes

2 Sep 2025

Countdown to the UNHLM

var PBCUtils = PBCUtils || {};
PBCUtils.ajaxurl = "https://www.healthycaribbean.org/wp-admin/admin-ajax.php";
PBCUtils.url = "https://www.healthycaribbean.org/wp-content/plugins/waiting/";
(function(){
if(!PBCUtils.loaded){
PBCUtils.loaded = true;
function PBC_Loader(){
PBCUtils.lang = {"fui":[],"units":{"years":"Years","months":"Months","weeks":"Weeks","days":"Days","hours":"Hours","minutes":"Minutes","seconds":"Seconds"}};
var script = document.createElement("script");
script.src = "https://www.healthycaribbean.org/wp-content/plugins/waiting/js/jquery.countdown.js";
script.setAttribute("data-cfasync", "false");
script.setAttribute("type", "text/javascript");
document.querySelector("head").appendChild(script);

script = document.createElement("script");
script.setAttribute("data-cfasync", "false");
script.setAttribute("type", "text/javascript");
script.src = "https://www.healthycaribbean.org/wp-content/plugins/waiting/js/pbc.js?v=0.8";
document.querySelector("head").appendChild(script);
var style = document.createElement("link");
style.rel = "stylesheet";
style.href = "https://www.healthycaribbean.org/wp-content/plugins/waiting/css/style.css?v=0.8";
style.type = "text/css";
document.querySelector("head").appendChild(style);
}
if(window.jQuery){PBC_Loader();}else { var pbctimer2324 = window.setInterval(function(){
if(window.jQuery){PBC_Loader(); window.clearInterval(pbctimer2324); }
}, 250);}
} else { if(PBCUtils.em) PBCUtils.em.trigger("pbc.run");}
}());

Webinar: Caribbean Regional Stakeholder Meeting on the 4th UN High-Level Meeting on NCDs and Mental Health

On Wednesday 30 July 2025, the Healthy Caribbean Coalition, in partnership with the Pan American Health Organisation, convened a virtual Caribbean Regional Stakeholder Meeting in support of the 4th UN High-Level Meeting (HLM4) on Non-communicable Diseases (NCDs) including Mental Health. This timely discussion also marked the 18th anniversary of the landmark 2007 Port of Spain Declaration on NCDs.

Panellist Quotes

1 of 15

Open Letter to CARICOM Heads of Government

In Response to the Official Communique of the 49th Regular Meeting of the Conference of Heads of Government July 6–8, 2025, Montego Bay, Jamaica

July 22, 2025

Dear Honourable Heads of Government and State of CARICOM,

The President and the Board of Directors of the Healthy Caribbean Coalition (HCC) note with disappointment the distinct absence of any mention of non-communicable disease (NCDs) and the upcoming  4th United Nations High-Level Meeting on NCDs and Mental Health (HLM4)  in the Communique of the Forty-Ninth Regular Meeting of the Conference of Heads of Government of the Caribbean Community (CARICOM).  The HLM4 will be held on September 25th, 2025 in New York during the 80th Meeting of the UN General Assembly under the theme “Equity and Integration: Transforming Lives and Livelihoods through Leadership and Action on Noncommunicable Diseases and the Promotion of Mental Health and Well-being.”

In HCCs Open Letter, we recalled the historical legacy of CARICOM leadership, engagement and participation in previous UN HLMs on NCDs, and called on CARICOM Leaders to deliver on five (5) key civil society asks:

1. Commit to continued leadership on NCD prevention and control and commit to attendance at the 4th UN High-Level Meeting on NCDs and Mental Health (HLM4) on September 25th, 2025 in the official Communiqué emerging from the Forty-Ninth Regular Meeting of the Conference of Heads of Government of the Caribbean Community (CARICOM).
2. Support the twelve Caribbean civil-society led advocacy priorities for inclusion in the official Communiqué from the Forty-Ninth Regular Meeting of the Conference of Heads of Government of the Caribbean Community and in the HLM4 Political Declaration [1].
3. Support one or more CARICOM Heads of Government or State to have a lead role in at least one of the multi-stakeholder panels at the HLM4.
4. Support the hosting of a high-level side-event on the margins of the HLM4 led by CARICOM Heads of Government and State as was done in past UN HLMs on NCDs.
5. Endorse the inclusion of a representative from a Civil Society Organisation (CSO) representing people living with NCDs and a youth representative in country delegations to the HLM4 in recognition of the whole-of-society response to NCDs.

Read the full letter

The 4th UN High Level Meeting on NCDs (HLM4) will take place 25 September 2025 in New York at the 80th United Nations General Assembly. Heads of States and Government will set a new vision to prevent and control NCDs towards 2030 and 2050 through a political declaration to be decided in the UN General Assembly. The Fourth High-level Meeting of the United Nations General Assembly (HLM4) provides a unique opportunity to adopt a new, ambitious and achievable political declaration on NCDs towards 2050.

Open Letter to CARICOM Heads of Government

Dear Honourable Heads of Government and State of CARICOM, On the occasion of this, the Forty-Ninth Regular Meeting of the Conference of Heads of Government of the Caribbean Community (CARICOM), the Healthy Caribbean Coalition (HCC) calls on you, Caribbean Heads of Government and State, to indicate your commitment to addressing one of our region’s most pressing development issues – noncommunicable diseases (NCDs) – by attending the 4th United Nations High-Level Meeting on NCDs and Mental Health (HLM4). The HLM4 will be held on September 25th, 2025 in New York during the 80th Meeting of the UN General Assembly under the theme “Equity and Integration: Transforming Lives and Livelihoods through Leadership and Action on Noncommunicable Diseases and the Promotion of Mental Health and Well-being.”

The HLM4 comes at a critical time when globally and in the Caribbean, rising rates of NCDs – namely cardiovascular diseases, diabetes, cancers, chronic respiratory diseases, and mental health conditions – are vastly outpacing prevention and control efforts. Eighteen years ago, CARICOM Member states played an important role in catapulting NCDs onto the global health agenda with the seminal Port of Spain Declaration. This was followed by the 1st UN High-Level Meeting on NCDs in 2011 which was attended by a significant number of CARICOM Heads who declared in a strong, unified voice that the prevention and control of NCDs was of the highest priority for the region. Almost 20 years after the 1st UN High-Level Meeting, progress in NCD prevention and control is uneven and the 2024 Port of Spain Grid and the 2025 WHO Progress Monitor both reflect a region grossly off track to meet critical regional and global NCD targets including the Sustainable Development Goal 3.4. NCDs are the leading cause of premature deaths in the Caribbean where 40% of NCD deaths occur prematurely before the age of 70 years. As unnecessary death and disability continue to rise, so do the associated costs of preventing and controlling these diseases which place a significant burden on the limited economic resources of CARICOM States – a crisis worsened by the impact of food and nutrition insecurity and climate-related disasters. Within the context of aging and contracting populations and increasing economic and climate vulnerabilities, bold action on NCDs focusing equally on prevention and treatment and care is critical to promoting a secure and sustainable future for the Caribbean.

Read the full letter
5 Key Asks of CARICOM Heads of Government and State

HCC-led Advocacy Priorities for HLM4

The HCC-led Caribbean Advocacy Priorities were developed with emphasis on the importance of identifying a set of regional priorities around which CARICOM missions and negotiators can promote at the HLM4; civil society and key advocacy partners can mobilise; and governments and key implementing partners can embrace – as all stakeholders work to accelerate progress to agreed priority NCD prevention and control objectives in CARICOM Member States. They take into consideration the WHO Best Buys and Other Recommended Interventions and CARICOM regional platforms and mandates, reflect and support the global NCDA advocacy priorities, and are further informed by key factors and realities within the Caribbean context.

The Healthy Caribbean Coalition, in collaboration with the NCD Alliance (NCDA), key stakeholders, and partners, has led a process to develop advocacy priorities to inform Caribbean Community (CARICOM) Member States’ advocacy at, and contribution to, the United Nations (UN) General Assembly Fourth High-level Meeting on the Prevention and Control of Noncommunicable Diseases (HLM4), scheduled for 25 September 2025 with the overall theme “Equity and Integration: Transforming lives and livelihoods through leadership and action on noncommunicable diseases and mental health”.

Read/download the full document

HCC-led Caribbean Advocacy Priorities summary View/download.

To see more detail on the Advocacy Priorities read/download the Priorities only document.

HLM4 Advocacy Priority Social Media Cards

1 of 12

Preparing CARICOM Ministries of Foreign Affairs for HLM4
Preparing CARICOM Ministries of Foreign Affairs for the Fourth United Nations High-Level Meeting on the Prevention and Control of Non-Communicable Diseases (HLM4) September 2025 and Beyond-  a Briefing Note From Civil Society.

The objective of the briefing note is to support the engagement of CARICOM Member States in the negotiations around the Political Declaration of HLM4. The briefing note presents the HCC-led Caribbean civil society advocacy priorities for HLM4; provides the rationale and evidence behind the advocacy priorities to support the negotiation process and contribute to effective Caribbean participation in the meeting; and sets the stage for continued advocacy for priority evidence-based NCD reduction strategies beyond HLM4.

Read/download the Briefing Note.

1 of 15

1 of 15
Caribbean NCD Leaders Spotlight

HCC spotlight on Caribbean NCD leaders leading up to the 4th UN High Level Meeting on NCDs (HLM4) held during the United Nations General Assembly in September 2025.

See our Caribbean NCD Leaders

HLM4 Key Milestones

Source: NCD Alliance with Caribbean-related insertions by HCC
UN Interactive Multistakeholder Hearing

Stephanie Whiteman

Maisha Hutton

Maria O’Brien

The Healthy Caribbean Coalition (HCC) recently attended the UN Interactive Multistakeholder Hearing (MSH) as part of the preparatory process for the Fourth high-level meeting of the General Assembly on the prevention and control of noncommunicable diseases and the promotion of mental health and well-being (HLM4) to be held on 25 September 2025 at the 80th UNGA. The purpose of the MSH is to gather broad stakeholder feedback on NCD and mental health priorities to inform the development of the zero draft of the Political Declaration.

Find out more

Read the official UN summary of the hearing here, this reflects the perspectives from Member States, civil society, youth, people living with NCDs, and other stakeholders.

The post The 4th UN High-level Meeting on NCDs appeared first on Healthy Caribbean Coalition.

Health authorities on Monday intensified calls for vigilance in Barbados amid regional outbreaks of chikungunya and new Oropouche virus cases, warning that the country’s tropical conditions leave it vulnerable despite no current outbreaks here.

The Pan American Health Organisation (PAHO) on Friday called for reinforcement of surveillance, clinical management, and vector control to tackle these outbreaks across the Americas. PAHO cautioned that the simultaneous presence of these and other arboviruses increases the risk of outbreaks, severe complications, and fatalities among vulnerable populations.

While Barbadian health officials are assuring the country that there is no outbreak of any of these or other viral diseases, the Ministry of Health says Zika, chikungunya, dengue, and Oropouche are of particular concern.

 “The diseases of concern to the ministry are Zika, chikungunya, and Oropouche, in addition to dengue fever. We recently reported to PAHO regarding cases of chikungunya in Barbados. We had 14 confirmed cases in 2024, and so far this year, we have had six confirmed cases,” Chief Medical Officer Dr Kenneth George told Barbados TODAY.

Dr George said that although chikungunya is transmitted via the bite of the Aedes aegypti mosquito and its symptoms are similar to those of dengue fever, there is a difference in the outcome.

The chief medical officer explained that chikungunya has a longer effect that persists for months after the infection has cleared.

The government’s top public health adviser pointed out that the levels of chikungunya remain low, with only six cases reported this year. He said the health ministry would carry out chikungunya and Zika screening if tests for dengue fever prove negative. 

“If we are receiving negative dengue cases, and persons are presenting with symptoms of mosquito-borne illness, we then do a wider screen for Zika, chikungunya and other viral agents,” he explained.

Dr George added: “We have not had any reported cases of Zika for several years. Remember, Zika is the infection that presents similarly to dengue, but is a cause for concern because it can affect pregnant women, leading to some form of birth defect. But there are no cases of Zika in Barbados for the past five years.”

Noting that the country experiences intermittent cases of chikungunya, he said the Ministry of Health will continue to conduct tests.

“We know that the vector Aedes aegypti mosquito is present … in Barbados,” the chief medical officer said. “Dengue is endemic in Barbados. We have always had dengue fever, but there is no outbreak of dengue on island at the moment.”

But, Dr George cautioned residents against becoming complacent: “Barbadians still need to play their part, not only in protecting themselves but in ensuring that breeding areas close to their properties are eliminated.”

On the Oropouche virus, which can be transmitted by sand flies, the top public health expert revealed that Barbados has not had any new cases for over a year and a half. But Barbadians can have confidence in the country’s surveillance system, he said.

“We have a strong surveillance system in Barbados that captures prevailing illnesses within the population. Our data suggests there is no Oropouche, so I have to believe it,” he declared.

According to a new epidemiological alert from PAHO, the largest chikungunya outbreaks have been concentrated in South America—particularly Bolivia, Brazil, and Paraguay—and in parts of the Caribbean. These are associated with the Asian and East/Central/South African (ECSA) genotypes, marking a shift in the pattern observed since 2014. Cases reported in the Indian Ocean region, Europe, and Asia also raise the risk of reintroduction and further spread into new areas with conditions conducive to transmission.

PAHO reports that as of August 9, 14 countries in the region reported a total of 212 029 suspected chikungunya cases and 110 deaths, with more than 97 per cent occurring in South America.

 In comparison, 2024 saw 431 417 reported cases and 245 deaths—indicating a decline this year, though localised outbreaks remain active.

In the first seven months of the year, over 12 700 confirmed Oropouche cases have been reported in 11 countries, including indigenous cases in Brazil, Colombia, Cuba, Panama, Peru, and Venezuela which were not attributed to travellers.

emmanueljoseph@barbadostoday.bb

The post Health authorities urge vigilance as region battles mosquito-borne viruses appeared first on Barbados Today.

The study was conducted by Alzahra and colleagues published in the journal of Dermatology and Therapy.

The meta-analysis was performed in line with PRISMA 2020 and registered on PROSPERO (CRD42023483130). Researchers performed an extensive literature search on Medline, EMBASE, and the Cochrane Library. Among 7,753 records identified, 6,378 were left after removing duplicates, and eventually 12 studies were included in the final review. Of these, six studies yielded data that were appropriate for quantitative meta-analysis.

Overall, the combined sample was representative of 3,267,951 participants, 289,322 of whom had vitiligo. Analysis focused specifically on malignancy risks for melanoma, non-melanoma skin cancer, and lymphoma—three cancer groups previously suspected to be affected by vitiligo-associated immune mechanisms.

Key Findings

• 12 studies were included in the final review.

• 6 studies were meta-analysis eligible.

• Total sample size: 3,267,951 participants.

•Vitiligo patients: 289,322 individuals.

• Pooled hazard ratio (HR) for lymphoma: 1.00 (95% CI 0.40–2.53), showing no significant increase in risk.

• Pooled HR for melanoma: 0.80 (95% CI 0.27–2.34), suggesting no consistent association and a possible—but unproven—protective effect.

• Pooled HR for non-melanoma skin cancer: 0.38 (95% CI 0.00–732.76), a highly variable result reflecting study heterogeneity.

This wide-ranging meta-analysis, encompassing more than 3.2 million participants, failed to identify any obvious correlation between cancer risk and vitiligo. While a protective role against certain malignancies remains a possibility, the enormous heterogeneity of study findings makes interpretation of conclusions highly cautious. Greater methodological rigor is needed to characterize the actual relationship between vitiligo and malignancy risk.

Reference:

Mohammed, A.A., Lengyel, A.S., Meznerics, F.A. et al. Cancer Risk in Vitiligo: No Evidence of Increased Prevalence—A Systematic Review and Meta-analysis. Dermatol Ther (Heidelb) (2025). https://doi.org/10.1007/s13555-025-01520-0

The Metropolitan Hospital of Santiago (HOMS) and the Centers for Diagnostics, Advanced Medicine, and Telemedicine (Cedimat) made history by introducing the MagDI System for bariatric surgery against obesity. It is a milestone in bariatric and metabolic surgery in the Dominican Republic.

HOMS, together with its Digestive, Bariatric, and Precision Surgery Institute, and in collaboration with Jenner Dominicana, performed the first Magnetic Bariatric Surgery in the Dominican Republic, Central America, and the Caribbean, consolidating its position as a regional benchmark in surgical innovation.

For the first time

Magnetic bariatric surgery, performed at Homs and Cedimat, is a hybrid procedure that creates a partial bypass of the small intestine (between the duodenum and ileum) by placing a magnet endoscopically in the duodenum and another laparoscopically in the ileum.

These magnets attract each other to form an anastomosis, which allows for a faster recovery with less pain, no blood loss, and a lower risk.

In Santiago, the procedure was attended by Rafael Sánchez Español, General Director and bariatric surgeon; Héctor Sánchez Navarro, Head of Robotic and Bariatric Surgery; and James Hamilton, Director of Innovation and Quality.

This team had the honor of welcoming Michel Gagner, a Canadian pioneer in bariatric surgery and creator of the MagDI technique used in this procedure. Also present were Brígida Navarro, gastroenterologist and director of the Center for Digestive Studies, and Luis Peralta.

From Cedimat

In its press release, the company states that it has consolidated its leadership in the treatment of obesity and type 2 diabetes with the introduction of the revolutionary MagDI system, a minimally invasive bariatric and metabolic technique that marks a significant milestone in Dominican medicine. This advancement was presented by Dr. Luis Alfredo Betances, director of the Bariatric and Metabolic Surgery Program at CEDIMAT, along with Dr. Michel Garnier (creator of the technology) at the Bariatric Institute.

This year, 2025, is not an epidemic year, and if the country receives an award for control, it should be given to other countries on the continent that have better indicators. Rodríguez Monegro referred to the statements of the Minister of Public Health, Víctor Atallah, who stated that the Dominican Republic has recorded a 78% reduction in dengue cases, thanks to the work carried out by provincial and regional health departments. For the pediatrician and former director of the SNS, the reduction in dengue cases is not due to any implemented strategy; rather, 2025 is a non-epidemic year with a low incidence of the disease. “The decline in dengue cannot be attributed to official campaigns, since when there is a dengue prevention and control campaign, it is felt in the community,” he said.

What is happening in all countries of the Americas is that there is a significant reduction in the incidence of dengue, because this is a year of low incidence and possibly the next one as well, unlike 2022 and 2023, he explained.

Under the criteria used by the Dominican authorities, all of America should be declared champions in the fight against dengue.

Official position

The Ministry of Health called on citizens to join efforts to reduce dengue transmission. The Ministry of Health continues to strengthen vector control efforts to reduce dengue transmission in the country. It stated that mosquito breeding site elimination campaigns, community education on hygiene habits, and fumigation efforts have been intensified.

The Ministry also stated that it has implemented various actions as part of the National Dengue Plan, intending to reduce the incidence of this disease. It also said it has relaunched the “eliminate, clean, and cover” campaign. This week, data for week 33 were released.

Preventive measures against dengue include eliminating mosquito breeding sites (such as stagnant water in containers and tires), protecting against mosquito bites with repellent, and using mosquito nets over beds, doors, and windows.

Public Health urges people to visit the nearest health center if they experience symptoms such as a sudden high fever, severe headache (especially behind the eyes), muscle and joint pain (“breakbone fever”), nausea, vomiting, and a skin rash.

A confirmed case of dengue was reported this week, bringing the total number of cases to 174.

Durante una cena bajo palmeras en la terraza de Mar-a-Lago en diciembre, el presidente electo Donald Trump tranquilizó a los directores ejecutivos de las farmacéuticas Eli Lilly y Pfizer diciéndoles que el activista antivacunas Robert F. Kennedy Jr. no sería una elección radical para dirigir el Departamento de Salud y Servicios Humanos (HHS).

“Creo que va a ser mucho menos radical de lo que imaginan”, aseguró Trump ese mismo mes durante una conferencia de prensa en su complejo turístico en Palm Beach, Florida.

Ocho meses después, Kennedy ha intensificado sus ataques contra el sistema de vacunación.

Uno de sus principales objetivos es un programa federal de compensación que resuelve reclamos de daños por vacunas.

Según algunos expertos legales y líderes en salud pública, su estrategia podría llevar a la quiebra o al debilitamiento del fondo, obligando a las farmacéuticas a asumir riesgos legales y costos que las llevarían a dejar de fabricar vacunas por completo.

“Es una agenda radical”, dijo Angela Rasmussen, viróloga de la Organización de Vacunas y Enfermedades Infecciosas de la Universidad de Saskatchewan en Canadá. “Está usando varios mecanismos distintos y realmente no hay límites. La gente va a empezar a darse cuenta, pero no será suficiente para detener la ola de muertes, incluidas las de niños”.

Kennedy ha dicho que es necesario reformar el sistema de vacunación en el país porque, según él —sin ofrecer evidencia—, las vacunas están relacionadas con el autismo, la neurotoxicidad, las alergias y la muerte. Es una de las figuras líderes del movimiento “Make America Healthy Again” (“Hagamos a Estados Unidos Saludable Otra Vez”), una campaña informal que rechaza la medicina tradicional y promueve la llamada “libertad médica”.

Muchos de sus seguidores se oponen a las vacunas y creen que son peligrosas, a pesar de la evidencia científica que demuestra lo contrario.

Kennedy ha reconocido que quiere reformar el fondo de vacunas, conocido como el Programa de Compensación por Lesiones Causadas por Vacunas (VICP, por sus siglas en inglés). El 28 de julio escribió en la red social X que “el VICP está roto, y pienso arreglarlo”. El Departamento de Salud y Servicios Humanos (HHS) está trabajando con el Departamento de Justicia para reformar el programa, que protege a las farmacéuticas de la mayoría de las demandas por lesiones.

El HHS no respondió a la solicitud de entrevista con Kennedy, pero funcionarios de la agencia dijeron que él no está en contra de las vacunas. “El secretario Kennedy no es antivacunas: está a favor de la seguridad, la transparencia y la rendición de cuentas”, dijo por correo electrónico Vianca Rodríguez Feliciano, vocera del HHS.

Sin embargo, según personas familiarizadas con las discusiones internas —que pidieron no ser identificadas porque no están autorizadas para hablar sobre el tema—, Kennedy ha estado trabajando en silencio para restringir la disponibilidad de vacunas ampliamente utilizadas.

Una estrategia con varios frentes

La estrategia comenzó a tomar forma en la primavera. El primer paso fue sembrar dudas infundadas sobre la seguridad de las vacunas. En una reunión de gabinete en abril, Kennedy le dijo a Trump que el HHS estaba realizando un estudio masivo para identificar la causa del aumento de diagnósticos de autismo para septiembre.

Según informes de prensa, Kennedy asignó la tarea a David Geier, un investigador que ha repetido la afirmación —ya desacreditada— de que las vacunas causan autismo.

Luego, Kennedy redobló la apuesta cuestionando el uso de aluminio, que se agrega a muchas vacunas para reforzar la respuesta inmunitaria. En una reunión de gobernadores en julio, lo vinculó con las alergias, a pesar de que un estudio reciente en la revista Annals of Internal Medicine no encontró ninguna conexión. Se espera ampliamente que pida a un comité asesor federal que revise el uso del aluminio.

La investigación sobre el autismo y las dudas sobre el aluminio fueron los primeros pasos en su ofensiva contra el fondo de compensación, según dos fuentes.

Ese fondo ofrece compensaciones a personas con lesiones causadas por vacunas y ha pagado más de $5.000 millones desde su creación en 1988, según la Administración de Recursos y Servicios de Salud (HRSA, por sus siglas en inglés).

Antes de presentar una demanda en un tribunal, las personas afectadas presentan sus reclamos ante el “tribunal de vacunas”, que no tiene jurado y evalúa la evidencia. El dinero proviene de un pequeño impuesto especial sobre cada vacuna.

La compensación se determina en parte por una tabla que mantiene la HRSA y supervisa el secretario del HHS. Esta lista enumera las vacunas y sus posibles efectos secundarios, y abarca las inmunizaciones de rutina recomendadas por los Centros para el Control y Prevención de Enfermedades (CDC), que están sujetas al impuesto. Las lesiones incluyen anafilaxia y encefalitis. Quienes sufran esas condiciones dentro de cierto tiempo después de vacunarse pueden recibir una indemnización.

Kennedy quiere que se incluyan el autismo o las alergias en esa tabla, según dos personas familiarizadas con las discusiones internas y con preocupaciones expresadas públicamente por farmacéuticas y ex funcionarios. Podría lograrlo, por ejemplo, si una investigación dirigida por el HHS vinculara las vacunas con el autismo, o si un comité asesor recomendara eliminar el aluminio de las vacunas.

“Dado el índice de autismo, si se presentan muchos casos, eso podría llevar a la quiebra del programa”, dijo Dorit Reiss, profesora de la Universidad de California en San Francisco.

Si eso ocurriera, algunas farmacéuticas podrían dejar de fabricar vacunas —que no suelen ser productos muy rentables— para evitar demandas largas y costosas de personas que no puedan ser compensadas porque el fondo federal se haya agotado, dijeron expertos en estas leyes y fabricantes.

“El fondo de compensación, si desaparece, afectaría la decisión de seguir adelante o no con las vacunas”, dijo David Dodd, presidente y director ejecutivo de GeoVax Labs, una empresa biotecnológica que desarrolla vacunas e inmunoterapias.

Kennedy ha puesto a personas de su confianza para llevar adelante esta estrategia. Ha presionado para que escépticos de las vacunas ocupen puestos clave en los CDC, que recomiendan las vacunas, y en la Administración de Alimentos y Medicamentos (FDA), que las aprueba.

También seleccionó a líderes del movimiento antivacunas para que evaluaran candidatos para su equipo.

El resultado ha sido una serie de decisiones regulatorias y políticas que han limitado el acceso a las vacunas y el desarrollo de nuevas.

Este mes, el HHS anunció que suspendía $500 millones en subvenciones y contratos para el desarrollo de vacunas de ARNm, incluidas versiones más duraderas contra covid.

El gobierno federal dejó de recomendar las vacunas contra covid para mujeres embarazadas sanas y para niños, sin consultar al comité asesor de vacunas que tradicionalmente participaba en esas decisiones.

Además, Kennedy reorganizó ese comité con miembros elegidos por él, incluidos escépticos de las vacunas, y eliminó como enlaces a grupos como la Asociación Médica Estadounidense, la Asociación Nacional de Enfermeras y otras organizaciones. El comité modificado recomendó no aplicar vacunas contra la gripe que contienen un conservante que erróneamente se ha vinculado con el autismo.

Las llamadas de la Casa Blanca

La intención de Kennedy de mantener a escépticos de las vacunas en puestos de supervisión se evidenció en un acuerdo que hizo recientemente con Trump y su equipo, según dos fuentes. El acuerdo se concretó un domingo de julio por la noche, cuando Kennedy recibió una llamada de la Casa Blanca.

El tema era Vinay Prasad, un alto regulador de vacunas de la FDA. Recientemente había provocado una oleada de críticas en la industria por haber participado en la decisión de la agencia de pedir a la empresa Sarepta Therapeutics que suspendiera la distribución de una terapia génica, por razones de seguridad.

Las redes sociales y comentaristas conservadores encendieron la polémica. Laura Loomer, una provocadora de extrema derecha, dijo el 21 de julio en X que Prasad debía ser despedido y lo llamó “liberal progresista autoproclamado y fanático de Bernie Sanders”, en referencia al senador Bernie Sanders (independiente por Vermont). Varios legisladores comenzaron a presionar a la Casa Blanca con preguntas.

La controversia llegó a Trump, quien quería que Prasad se fuera, según las fuentes. Pero Kennedy no quería perderlo. Consideraba que necesitaba a alguien crítico de las vacunas al frente de la supervisión en la agencia.

Así que Kennedy negoció. A Prasad se le pediría que renunciara como director del Centro de Evaluación e Investigación de Productos Biológicos de la FDA, que regula vacunas y productos biológicos como las terapias génicas. Y el centro se dividiría en dos operaciones, lo que le permitiría a Kennedy elegir quién estaría a cargo del área de vacunas.

Algunos líderes en salud pública compartieron públicamente detalles del acuerdo y expresaron su preocupación. Scott Gottlieb, ex comisionado de la FDA, dijo el 1 de agosto en CNBC que pensaba que “sería muy destructivo para la agencia”.

Después de dejar la agencia en julio, Prasad ahora regresa, aunque no está claro si en el mismo cargo.

Recientemente, Kennedy fue demandado por Ray Flores, abogado externo principal de Children’s Health Defense, una organización antivacunas fundada por el propio Kennedy.

La demanda —financiada por esa organización— alega que Kennedy no lanzó un grupo de trabajo para estudiar la seguridad de las vacunas, como supuestamente se exige. Sin embargo, según una fuente, Kennedy y sus aliados consideran que se trata de una demanda “amigable” porque busca un resultado que él mismo desea.

El 14 de agosto, el HHS anunció que reactivaría un panel federal —disuelto en 1998— para supervisar las vacunas pediátricas.

Las acciones de Kennedy contra las vacunas también han generado demandas en su contra, incluida una presentada por la Academia Americana de Pediatría y otros grupos de salud pública. Su decisión de detener el financiamiento para el desarrollo de vacunas de ARNm provocó una oleada de críticas en redes sociales.

“Esto es irresponsable. Es peligroso. Va a costar vidas. Debemos contraatacar”, escribió el 5 de agosto el senador Edward Markey (demócrata por Massachusetts) en X.

“Intenté mantenerme objetivo y sin alarmismo frente a las acciones del HHS, pero sinceramente, esta medida va a costar vidas”, dijo ese mismo día Jerome Adams, ex cirujano general de Estados Unidos durante el anterior gobierno de Trump.

Kennedy y sus seguidores siguen decididos. En respuesta, sus aliados lanzaron una campaña de relaciones públicas sin precedentes para promover la figura del secretario de Salud, alimentando la especulación de que podría estar considerando una candidatura presidencial en 2028.

La organización sin fines de lucro MAHA Action organizó una llamada en julio para movilizar a los seguidores de Kennedy e inició una campaña publicitaria de seis cifras elogiando a Kennedy y a las iniciativas de salud del gobierno de Trump.

“Que no quepa duda: esta es una revolución que cambiará el rostro de las políticas de salud pública”, dijo Tony Lyons, presidente de MAHA Action, en un comunicado. “Los estadounidenses están exigiendo una transparencia radical y ciencia de primer nivel”.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).

View the full post GHTA launches free prostate cancer screenings on NOW Grenada.